Only the live session qualifies for CEUs but when possible, we host the recordings on our website and NSGC recommends participants to use their personal email instead of work email addresses to ensure they receive their CEU certificates.
Ambry Genetics is approved as a provider for continuing education program by NSGC and ASCLS P.A.C.E ® Program.
Dr. Matthew Might has been the Director of the Hugh Kaul Precision Medicine Institute at the University of Alabama at Birmingham (UAB) since 2017. At UAB, Dr. Might is the Hugh Kaul Kaul Endowed Chair of Personalized Medicine, a Professor of Internal Medicine and a Professor of Computer Science.
From 2016 to 2018, Dr. Might was a Strategist in the Executive Office of the President in The White House. And, in 2015, Dr. Might joined the faculty of the Department of Biomedical Informatics at the Harvard Medical School.
Dr. Might's journey from computer science to medicine has been inspired by his son Bertrand. In 2012, Bertrand became the first patient in the world to be diagnosed with NGLY1 deficiency, and this inspired Dr. Might to use social media to discover other patients and form a community. Through the community's efforts in science, two therapeutics for NGLY1 deficiency have been identified since its discovery, and more are under active development. Dr. Might is co-founder and Chief Scientific Officer of NGLY1.org, and he is a co-founder and Scientific Advisor to Pairnomix.
Dr. Might received his B.S. (2001), M.S. (2005) and Ph.D. (2007) in computer science from Georgia Tech.
Dr. Might tweets from @mattmight and blogs at blog.might.net.
Erica received her BS at University of California, San Diego, in Animal Physiology and Neuroscience and a PhD at University of California, Irvine in Neurobiology and Behavior, in an Alzheimer’s lab led by Carl Cotman. Her thesis established the molecular response of hippocampal neurons to simultaneous growth signals such as those from Brain Derived Neurotrophic Factor (BDNF) and inflammatory cytokines. Erica then completed post-doctoral research in a blood-brain-barrier lab with Dritan Agalliu, studying an animal model of PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus). She studied the effect of repeated strep throat infections on mouse brains. At Ambry, Erica specializes in evaluating clinical validity, or the evidence linking genes to specific diseases.
Subscribe to receive notifications for future webinars.
Subscribe